Press Releases
Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies
Feb 01, 2018
Imago BioSciences Doses First Patients in Phase 1/2 Study of IMG-7289 in Myelofibrosis
Sep 19, 2017
Imago BioSciences Doses First Patients in the Phase 2a Portion of the Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Jul 19, 2017
Imago BioSciences Enrolls First Patient in Phase 1/2 Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Nov 08, 2016
Imago BioSciences Announces Preclinical Data on LSD1 Inhibitor at Annual Meeting of the American Society of Hematology (ASH)
Dec 07, 2015
Displaying 41 - 45 of 46